|
⚲
|
| Keyboard |
| Ardsley Advisory Partners
✚
|
|
|---|---|
| CRD # | 160595 |
| SEC # | 801-73664 |
| CIK # | 0000900529 |
| AUM | |
| Employees | 13 (54% Investors, 0% Brokers) |
| Phone | 203-564-4200 |
| Address | 262 Harbor Drive Stamford, CT 06902 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Sandisk Corp | 56.7 | ||
| Advanced Micro Devices Inc | 54.0 | ||
| Sezzle Inc | 36.9 | ||
| Ikonics Corp | 23.7 | ||
| BrightSpring Health Services Inc | 22.7 | ||
| eBay Inc | 22.3 | ||
| Sunrun Inc | 21.4 | ||
| JDS Uniphase Corp /CA/ | 18.6 | ||
| ARM Holdings PLC /UK | 16.6 | ||
| Shoals Technologies Group Inc | 16.5 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Ardsley Ridgecrest Partners Fund LP | [2014-03-28] | 30.3 M | 26.3 M |
| Filed 2024-11-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Ardsley Offshore Fund Ltd | [2012-02-14] | 4.8 M | 15.2 M |
| Filed 2012-03-12 (D/A) · Exemption 506, 3(c)(1) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Ardsley Partners Institutional Fund LP | 2012-02-14 | 198.0 M | |
| HF | Ardsley Renewable Energy Offshore Fund Ltd | [2012-02-14] | 5.0 M | 4.7 M |
| Filed 2012-03-12 (D/A) · Exemption 506, 3(c)(1) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 895.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 895.3 |
| By Discretionary | ||
| Discretionary | 7 | 895.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 895.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 895.3 | |
| Total | 7 | 895.3 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Neil Glass | Director | 20 | 9 | |
| Philip Hempleman | Executive Officer | 8 | 3 | |
| Ardsley Advisory Partners LP | Promoter | 8 | 3 | |
| Spencer Hempleman | Executive Officer | 8 | 3 | |
| Ardsley Partners I GP LLC | Executive Officer | 8 | 3 | |
| Ardsley Partners I | Executive Officer | 3 | 3 | |
| Willy Weber | Director | 3 | 2 | |
| Ardsley Advisory Partners | Promoter | 3 | 2 | |
| Steven Napoli | Director | 2 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0000900529] | |
| 3 | [0000900529] | |
| 4 | [0000900529] | |
| SC 13D | [0000900529] | |
| SC 13G | [0000900529] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.7B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300GQR5ULS7W2C050 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2021-11-11 | Option exercise | 618,014 | $0.75 | 463,510 |
|
Marrone Bio Innovations Inc MBII
Common Stock
|
2021-11-11 | Option exercise | 618,014 | $0.75 | 463,510 |
|
Marrone Bio Innovations Inc MBII
Common Stock
|
2021-03-12 | Option exercise | 741,617 | $0.75 | 556,213 |
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2021-03-12 | Option exercise | 741,617 | $0.75 | 556,213 |
|
Marrone Bio Innovations Inc MBII
Common Stock
|
2020-12-31 | Other | 50,000 | $1.26 | 63,000 |
|
Marrone Bio Innovations Inc MBII
Common Stock
|
2020-12-31 | Other | 50,000 | $1.26 | 63,000 |
|
Marrone Bio Innovations Inc MBII
Common Stock
|
2020-12-14 | Option exercise | 1,648,037 | $0.75 | 1,236,028 |
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-12-14 | Option exercise | 1,648,037 | $0.75 | 1,236,028 |
|
Marrone Bio Innovations Inc MBII
Common Stock
|
2020-09-15 | Option exercise | 343,341 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-09-15 | Option exercise | 343,341 | $0.75 | 257,506 |
|
SunOpta Inc STKL
Common Stock
|
2020-08-18 | Sell | 2,300,000 | $6.00 | 13,800,000 |
|
SunOpta Inc STKL
Common Stock
|
2020-08-18 | Sell | 1,000,000 | $6.00 | 6,000,000 |
|
SunOpta Inc STKL
Common Stock
|
2020-08-06 | Sell | 12,500 | $6.77 | 84,625 |
|
SunOpta Inc STKL
Common Stock
|
2020-08-05 | Sell | 50,000 | $6.31 | 315,500 |
|
SunOpta Inc STKL
Common Stock
|
2020-08-05 | Sell | 25,000 | $6.56 | 164,000 |
|
SunOpta Inc STKL
Common Stock
|
2020-08-05 | Sell | 25,000 | $7.10 | 177,500 |
|
Marrone Bio Innovations Inc MBII
Common Stock
|
2020-05-01 | Option exercise | 429,176 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-05-01 | Option exercise | 429,176 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Grant | 741,617 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Grant | 1,648,037 | ||
| showing 20 of 83 most recent transactions | |||||